
Company valuation, historical trends, and peer comparisons.
According to Kodiak Sciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.01B. This represents a change of 241.09% compared to the average of 1.76B of the last 4 quarters.
The mean historical Enterprise Value of Kodiak Sciences Inc. over the last ten years is 345.88M. The current 6.01B Enterprise Value has changed 1.64% with respect to the historical average. Over the past ten years (40 quarters), KOD's Enterprise Value was at its highest in in the June 2026 quarter at 2.41B. The Enterprise Value was at its lowest in in the March 2022 quarter at -87598073.04.
Average
345.88M
Median
330.81M
Minimum
-37317116.10
Maximum
1.44B
Discovering the peaks and valleys of Kodiak Sciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.00%
Maximum Annual Enterprise Value = 1.44B
Minimum Annual Increase = -997.31%
Minimum Annual Enterprise Value = -37317116.10
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.44B | 237.75% |
| 2024 | 425.47M | 667.12% |
| 2023 | 55.46M | -85.07% |
| 2022 | 371.40M | 13.66% |
| 2021 | 326.77M | -31.48% |
| 2020 | 476.90M | 42.42% |
| 2019 | 334.85M | -997.31% |
| 2018 | -37317116.10 | -159.62% |
| 2017 | 62.60M | 1.00% |
The current Enterprise Value of Kodiak Sciences Inc. (KOD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
639.32M
5-year avg
523.23M
10-year avg
345.88M
Kodiak Sciences Inc.’s Enterprise Value is greater than EyePoint Pharmaceuticals, Inc. (-56633745.00), greater than Outlook Therapeutics, Inc. (122.85M), greater than Oculis Holding AG (398.68M), greater than Kiora Pharmaceuticals, Inc. (1.18M), greater than Ocugen, Inc. (236.03M), greater than Ocular Therapeutix, Inc. (968.05M), less than Regeneron Pharmaceuticals, Inc. (99.13B), less than Bausch + Lomb Corporation (11.76B), less than Belite Bio, Inc (6.23B), greater than 4D Molecular Therapeutics, Inc. (601.67M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -56633745.00 | $31.46M | |
| 122.85M | $115.66M | |
| 398.68M | $484.08M | |
| 1.18M | $7.92M | |
| 236.03M | $248.09M | |
| 968.05M | $1.49B | |
| 99.13B | $100.08B | |
| 11.76B | $7.18B | |
| 6.23B | $6.23B | |
| 601.67M | $632.82M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kodiak Sciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kodiak Sciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Kodiak Sciences Inc.'s Enterprise Value?
What is the highest Enterprise Value for Kodiak Sciences Inc. (KOD)?
What is the 3-year average Enterprise Value for Kodiak Sciences Inc. (KOD)?
What is the 5-year average Enterprise Value for Kodiak Sciences Inc. (KOD)?
How does the current Enterprise Value for Kodiak Sciences Inc. (KOD) compare to its historical average?